Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-47
SponsorGeneration Next Fertility
About this trial
Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.
Eligibility criteria
Qualifiers
No none contraindications to IVF or PRP treatment
Adequate ovarian reserves and AMH level
Willingness to undergo two IVF cycles and oPRP treatment
Disqualifiers
Anovulation due to menopause or perimenopause
Any health conditions that are contraindicated for IVF or oPRP treatment
Trial design
Treatments tested in this trial
- Ovarian Platelet-rich plasma (PRP) injections
Treatment groups
180 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov